Hearscape
← Companies
Company

Norgine

Company-level hearing-loss landscape profile across checked programs, evidence quality, modalities, indications, and open data checks.

All ProgramsTherapeuticsDevices
Open filtered programs
Programs
1
linked to organization
Strong Evidence
1
1 status confirmed
Details Checked
1
0 open data checks
Company / Institution Links
1 / 0
industry vs non-industry records
Competitive Density
3
Pipeline Velocity
30
Completion Signal
100

Programs by Stage

Marketed1

Trial / Program Status

Marketed1

Modality Mix

Small Molecule1

Indication Coverage

Cisplatin-Induced Hearing Loss1
Hearing Loss1

Program Types

Therapeutic1

Population Tags

cisplatin-ototoxicity1
pediatric1

Strong-Evidence Records

1 records
PEDMARK by Fennec Pharmaceuticals
Strong evidence
Small MoleculeMarketedMarketed

Systemic sodium thiosulfate reduces cisplatin-associated ototoxicity by chemically inactivating reactive platinum species after chemotherapy.

Checked Records With Caveats

1 checked · 0 open checks